Integrative analysis of homologous recombination repair patterns unveils prognostic signatures and immunotherapeutic insights in breast cancer
Journal of Applied Genetics · 2024
DOI: 10.1007/s13353-024-00848-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Genetics, 2024. Verfasst von Yan-Shuang Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Immunotherapy, Gene Expression Regulation, Neoplastic, Recombinational DNA Repair. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Globally, breast cancer (BC) is the leading cause of female death and morbidity. Homologous recombination repair (HRR) is critical in BC. However, the prognostic role and immunotherapy response of HRR in BC remains to be clarified. Firstly, we identified HRR types in BC samples from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) dataset (GSE42568) based on 65 HRR genes (HRRGs). A differentially expressed gene (DEG) list for different HRR types was generated. Then, the influences of gene sets composed of these DEGs on biological pathways and BC prognosis were explored. Next, we identified gene clusters based on gene sets composed of DEGs. Genes associated with prognosis for DEGs were identified using univariate Cox regression. Finally, the HRR score was constructed based on genes associated with prognosis. We analyzed how HRR score correlates with tumor mutation burden (TMB), immune cell infiltration (ICI), and immunotherapy response. Three HRR clusters were discovered. HRR subtype A demonstrated decreased infiltration and a high number of immunosuppressive cells with a poor prognosis. DEGs among various HRR types were predominantly enriched in cell cycle and genomic stability-related pathways. The prognostic model based on sixteen DEGs accurately predicted BC prognosis. The HRRGs were differentially expressed in three DEG clusters. TMB, ICI, and immunotherapy responses differed significantly between the high and low HRR groups (HSG, LSG). The HSG was distinguished by a high degree of ICI and low TMB. LSG had a better response to anti-PD-1 or anti-PD-1 and anti-CTLA4 combination therapy. This work revealed that HRR patterns would contribute to predicting prognosis and immunotherapy response in BC, which may benefit patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
- Department of Breast Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. dr.jianghongchuan@gmail.com.
Zitieren
APA
Li, Y. S., & Jiang, H. C. (2024). Integrative analysis of homologous recombination repair patterns unveils prognostic signatures and immunotherapeutic insights in breast cancer. Journal of Applied Genetics. https://doi.org/10.1007/s13353-024-00848-1
Vancouver
Li YS, Jiang HC. Integrative analysis of homologous recombination repair patterns unveils prognostic signatures and immunotherapeutic insights in breast cancer. Journal of Applied Genetics. 2024. doi:10.1007/s13353-024-00848-1
BibTeX
@article{Li2024,
author = {Li, Yan-Shuang and Jiang, Hong-Chuan},
title = {Integrative analysis of homologous recombination repair patterns unveils prognostic signatures and immunotherapeutic insights in breast cancer},
journal = {Journal of Applied Genetics},
year = {2024},
doi = {10.1007/s13353-024-00848-1}
}
EUVIMED